High lipoprotein(a): Actionable strategies for risk assessment and mitigation
American Journal of Preventive Cardiology · 2024-06 · 18 · 100651
DOI: 10.1016/j.ajpc.2024.100651 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Preventive Cardiology, 2024-06. Verfasst von Gissette Reyes-Soffer und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Columbia University Irving Medical Center, NY, USA. Die Arbeit wurde bisher 76-mal zitiert (Crossref) und nennt 161 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Novartis Pharma AG, Novartis.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Columbia University Irving Medical Center, NY, USA.
- Department of Medicine, UC San Diego Health, CA, USA.
- Division of Cardiology, Johns Hopkins University School of Medicine, MD, USA.
- Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
- Baylor College of Medicine, TX, USA.
Förderung
- Novartis Pharma AG
- Novartis
Zitieren
APA
Reyes-Soffer, G., Yeang, C., Michos, E. D., Boatwright, W., & Ballantyne, C. M. (2024). High lipoprotein(a): Actionable strategies for risk assessment and mitigation. American Journal of Preventive Cardiology, 18, 100651. https://doi.org/10.1016/j.ajpc.2024.100651
Vancouver
Reyes-Soffer G, Yeang C, Michos ED, Boatwright W, Ballantyne CM. High lipoprotein(a): Actionable strategies for risk assessment and mitigation. American Journal of Preventive Cardiology. 2024;18:100651. doi:10.1016/j.ajpc.2024.100651
BibTeX
@article{ReyesSoffer2024,
author = {Reyes-Soffer, Gissette and Yeang, Calvin and Michos, Erin D and Boatwright, Wess and Ballantyne, Christie M},
title = {High lipoprotein(a): Actionable strategies for risk assessment and mitigation},
journal = {American Journal of Preventive Cardiology},
year = {2024},
volume = {18},
pages = {100651},
doi = {10.1016/j.ajpc.2024.100651}
}
EUVIMED